If you are searching for peptides UAE, you have already done the hard work — you have moved past the noise and landed on the molecule that re-wrote the GLP-1 category. REVIVE LAB UAE is the trusted peptides supplier in Dubai for researchers who want retatrutide same day delivery UAE, HPLC-tested vials, and a protocol they can actually run in twelve weeks. This guide is the compact version of the Jastreboff 2023 NEJM ramp — the same titration logic, condensed for the researcher who needs measurable outcomes before the calendar runs out.
Retatrutide is the first triple agonist peptide — it activates GLP-1, GIP and glucagon receptors simultaneously. That third receptor is the reason 12-week numbers exist at all. GLP-1 alone (semaglutide) and GLP-1+GIP (tirzepatide) take 16-20 weeks to show comparable curves. With retatrutide, the appetite suppression and energy expenditure shift both arrive faster, which is exactly what makes a 12-week window viable.
The Phase 2 NEJM trial (Jastreboff et al., 2023) titrated subjects every 4 weeks. That is non-negotiable — going faster compounds GI side effects and forces discontinuation. A compact protocol respects the 4-week step, just stops at the 4 mg target instead of climbing all the way to 12 mg. The trade-off is honest: you get roughly one-third of the 48-week loss in one-quarter of the time, with a fraction of the side-effect tax.
Realistic outcomes from the 4 mg arm of Jastreboff 2023 at the 12-week checkpoint: 6 to 10% body weight reduction, waist circumference down 5-8 cm, fasting glucose normalised in prediabetic subjects, triglycerides down 20-30%. The appetite quieting hits around day 10 and never really leaves while the molecule is in your system.
| Week | Dose | Units (1 mL syringe, 5 mg vial in 2 mL BAC) | What to expect |
|---|---|---|---|
| 1-4 | 0.5 mg weekly SC | 20 units | System adapting; mild GI flutter |
| 5-8 | 1 mg weekly SC | 40 units | Appetite drop noticeable; food noise quiets |
| 9-10 | 2 mg weekly SC | 80 units | Fat loss accelerates; energy stabilises |
| 11-12 | 4 mg weekly SC | 160 units (split into two 80-unit shots if preferred) | Plateau pressure relief; final cut |
One retatrutide 5mg vial reconstituted with 2 mL of BAC water gives you a concentration of 2.5 mg/mL. At the dose ramp above, a single 5 mg vial covers the first 8 weeks comfortably and a second covers weeks 9-12. Researchers running the protocol on a single 10 mg vial (reconstituted with 3 mL BAC) get the full 12 weeks from one vial with margin to spare — better economics for anyone in Emirates Hills, Arabian Ranches, or Dubai Hills who would rather receive one cold-chain shipment than two.
Subcutaneous injection into abdomen or thigh, rotating sites weekly. A 29G or 31G insulin needle is standard — short enough to stay in subcutaneous tissue, fine enough to be effectively painless. Store the reconstituted vial in the fridge at 2-8°C; shelf life of the reconstituted solution is approximately 30 days, which aligns neatly with the monthly dose total.
Retatrutide is a lyophilized peptide. Cold chain matters. REVIVE LAB UAE dispatches every order in insulated packaging with gel packs, tracked by a UAE courier network that covers every emirate. Typical windows:
REVIVE Peptides UAE is the destination for researchers who want their peptides Dubai shipment to arrive intact, on time, and exactly as labelled. Every batch of retatrutide is HPLC-verified for purity above 98% with a certificate available on request. Vials ship in cold-chain courier packaging, with discreet outer wrap and anonymous billing. We hold both the retatrutide 5 mg and retatrutide 10 mg SKUs in stock — no backorders, no "next week" excuses — and dispatch from a UAE-based facility, which is why same-day in Dubai is a normal Tuesday for us. Browse all REVIVE Peptides UAE products →.
Researchers running the 12-week ramp often pair it with adjuncts already familiar to the peptides UAE community:
REVIVE LAB UAE stocks retatrutide 5 mg and retatrutide 10 mg vials and ships same-day in Dubai and Sharjah, next-day to Abu Dhabi, Ajman, RAK, Fujairah and Umm Al Quwain. Cold-chain courier, discreet packaging, cash on delivery available.
The 4 mg arm of Jastreboff 2023 reached ~7-9% by the 12-week mark in the published cohort. A compact ramp to 4 mg with reasonable adherence produces 6-10% body weight loss for most researchers, with the bulk of fat loss in weeks 5-12.
For a 12-week window, yes — the glucagon component accelerates the early curve. Tirzepatide is the gold standard for the 18-month maintenance picture, but if your deadline is in Q4 2026 retatrutide produces results faster. See our retatrutide vs tirzepatide vs semaglutide breakdown.